# A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

Study · id `cardio:ct-nct05056727` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05056727](<https://clinicaltrials.gov/study/NCT05056727>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05056727

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1112 participants.

## Technical summary

Registry record NCT05056727. Randomized; quadruple masking; primary purpose treatment. Start 2021-09-30 (actual); primary completion 2024-02-07 (actual). Results posted on 2026-01-08.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1112 participants (enrolled count; ClinicalTrials.gov record NCT05056727, source copy `cardio:ctgov-nct05056727-2026-01-08`, retrieved 2026-10-26)
- Started: 2021-09-30 (actual) (ClinicalTrials.gov record NCT05056727, source copy `cardio:ctgov-nct05056727-2026-01-08`, retrieved 2026-10-26)
- Primary completion: 2024-02-07 (actual) (ClinicalTrials.gov record NCT05056727, source copy `cardio:ctgov-nct05056727-2026-01-08`, retrieved 2026-10-26)
- Completion: 2024-02-07 (actual) (ClinicalTrials.gov record NCT05056727, source copy `cardio:ctgov-nct05056727-2026-01-08`, retrieved 2026-10-26)
- Results first posted: 2026-01-08 (ClinicalTrials.gov record NCT05056727, source copy `cardio:ctgov-nct05056727-2026-01-08`, retrieved 2026-10-26)
- Countries: United States; Argentina; Brazil; Bulgaria; Canada; China; India; Italy; Japan; Malaysia; Mexico; Philippines; Poland; Puerto Rico; Russia; Spain; Taiwan; Thailand; Türkiye; Ukraine; Vietnam (ClinicalTrials.gov record NCT05056727, source copy `cardio:ctgov-nct05056727-2026-01-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05056727-2026-01-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
- Acronym: STABILIZE-CKD
- Condition: Renal Insufficiency, Chronic
- Condition: Hyperkalemia
- Intervention (Drug): Sodium Zirconium Cyclosilicate (SZC)
- Intervention (Drug): Placebo
- Intervention (Drug): Lisinopril
- Intervention (Drug): Valsartan
- Intervention (Drug): Irbesartan
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry intervention name matches this record: Lisinopril (`cardio:lisinopril`)
- Registry intervention name matches this record: Valsartan (`cardio:valsartan`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)

## Provenance

Content hash: 4c6e9d712ca33a54d29b6bc14baca93a2e8480b778027d3a21270dbd6f148eb1
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
